𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer

✍ Scribed by Judd W. Moul

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
71 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

The current issue of Cancer includes a report on a concise, randomized controlled trial (RCT) with long‐term follow‐up that favors combined androgen blockade with bicalutamide versus lutenizing hormone‐releasing hormone monotherapy in Japanese men with locally advanced and metastatic prostate cancer. It has been 20 years since the first RCT on CAB was published, and the debate continues.

📜 SIMILAR VOLUMES

Systematic review and meta-analysis of m
Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma
✍ David J. Samson; Jerome Seidenfeld; Brian Schmitt; Vic Hasselblad; Peter C. Albe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## Abstract ## BACKGROUND The current systematic review and meta‐analysis compared monotherapy and combined androgen blockade in the treatment of men with advanced prostate carcinoma. Outcomes of interest included overall, cancer specific, and progression‐free survival; time to treatment failure;